Telix Pharmaceuticals TLX recently announced a major step in expanding access to its next-generation prostate cancer imaging ...

This was the stock's third consecutive day of losses.

Following recent U.S. Food and Drug Administration (FDA) approval 2, and in preparation for commercial launch in H1 2025, Telix has contracted with Cardinal Health to enable availability across a wide ...

The stock's rise snapped a four-day losing streak.

Over the past year, many Cardinal Health, Inc. ( NYSE:CAH ) insiders sold a significant stake in the company which ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...

The latest trading session saw Cardinal Health (CAH) ending at $137.09, denoting a -1.14% adjustment from its last day's close. The stock exceeded the S&P 500, which registered a loss of 4.84% for the ...

Your FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to ...

Cardinal Health Inc. hit a new 52-week high, surpassing its previous peak of $138.62, which the company reached on March 31st ...

Year-Old. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against other stocks ...

Profits at the Tullamore-based operation of US medical device maker Cardinal Health soared 20pc last year to €6m even as it ...

The latest trading session saw Cardinal Health (CAH) ending at $137.09, denoting a -1.14% adjustment from its last day's close. The stock exceeded the S&P 500, which registered a loss of 4.84% for ...